92 related articles for article (PubMed ID: 12674040)
21. Natural rubber latex allergy in children: clinical and immunological effects of 3-years sublingual immunotherapy.
Bernardini R; Pecora S; Milani M; Burastero SE
Eur Ann Allergy Clin Immunol; 2008 Dec; 40(4):142-7. PubMed ID: 19227650
[TBL] [Abstract][Full Text] [Related]
22. Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.
Horak F; Zieglmayer P; Zieglmayer R; Lemell P; Devillier P; Montagut A; Mélac M; Galvain S; Jean-Alphonse S; Van Overtvelt L; Moingeon P; Le Gall M
J Allergy Clin Immunol; 2009 Sep; 124(3):471-7, 477.e1. PubMed ID: 19647862
[TBL] [Abstract][Full Text] [Related]
23. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
24. Sublingual immunotherapy: from safety to mechanism of action.
Marcucci F; Sensi L; Allocca G; Chiarello F; Palleri P; Ugolini E; Di Rienzo A; Castellani S; Incorvaia C; Di Cara G; Puccinelli P; Frati F
Eur Ann Allergy Clin Immunol; 2007 Mar; 39(3):101-3. PubMed ID: 17465282
[TBL] [Abstract][Full Text] [Related]
25. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care.
Röder E; Berger MY; Hop WC; Bernsen RM; de Groot H; Gerth van Wijk R
J Allergy Clin Immunol; 2007 Apr; 119(4):892-8. PubMed ID: 17321581
[TBL] [Abstract][Full Text] [Related]
26. A bright future for sublingual immunotherapy--contra.
Kleine-Tebbe J
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):242-50; discussion 250-2. PubMed ID: 17393746
[TBL] [Abstract][Full Text] [Related]
27. Sublingual immunotherapy: administration, dosages, use.
Frati F; La Grutta S; Bernardini R; Zampogna S; Scurati S; Puccinelli P; Riario-Sforza GG; Incorvaia C
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):13-6. PubMed ID: 19944004
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
La Grutta S; Arena A; D'Anneo WR; Gammeri E; Leonardi S; Trimarchi A; Platania D; La Rosa M
Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
[TBL] [Abstract][Full Text] [Related]
29. Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children.
Ibañez MD; Kaiser F; Knecht R; Armentia A; Schöpfer H; Tholstrup B; Bufe A
Pediatr Allergy Immunol; 2007 Sep; 18(6):516-22. PubMed ID: 17680910
[TBL] [Abstract][Full Text] [Related]
30. Sublingual immunotherapy for Japanese cedar pollinosis.
Okubo K; Gotoh M
Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
[TBL] [Abstract][Full Text] [Related]
31. Sublingual immunotherapy for large local reactions caused by honeybee sting: a double-blind, placebo-controlled trial.
Severino MG; Cortellini G; Bonadonna P; Francescato E; Panzini I; Macchia D; Campi P; Spadolini I; Canonica WG; Passalacqua G
J Allergy Clin Immunol; 2008 Jul; 122(1):44-8. PubMed ID: 18468672
[TBL] [Abstract][Full Text] [Related]
32. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
33. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.
Rolinck-Werninghaus C; Wolf H; Liebke C; Baars JC; Lange J; Kopp MV; Hammermann J; Leupold W; Bartels P; Gruebl A; Bauer CP; Schnitker J; Wahn U; Niggemann B
Allergy; 2004 Dec; 59(12):1285-93. PubMed ID: 15507097
[TBL] [Abstract][Full Text] [Related]
34. Sublingual immunotherapy in the treatment of children.
Pham-Thi N; de Blic J; Scheinmann P
Allergy; 2006; 61 Suppl 81():7-10. PubMed ID: 16792599
[TBL] [Abstract][Full Text] [Related]
35. Side-effects of injective allergen immunotherapy administered to intermittent or persistent allergic rhinitis patients.
Rogala B; Markiewicz-Bendkowska IB; Brzoza Z; Glück J; Oleś E
Rhinology; 2007 Jun; 45(2):134-9. PubMed ID: 17708460
[TBL] [Abstract][Full Text] [Related]
36. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S
Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
[TBL] [Abstract][Full Text] [Related]
37. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
Amar SM; Harbeck RJ; Sills M; Silveira LJ; O'Brien H; Nelson HS
J Allergy Clin Immunol; 2009 Jul; 124(1):150-156.e1-5. PubMed ID: 19523672
[TBL] [Abstract][Full Text] [Related]
38. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial.
Kleine-Tebbe J; Ribel M; Herold DA
Allergy; 2006 Feb; 61(2):181-4. PubMed ID: 16409193
[TBL] [Abstract][Full Text] [Related]
39. Safety of various dosage regimens during induction of sublingual immunotherapy. A preliminary study.
Grosclaude M; Bouillot P; Alt R; Leynadier F; Scheinmann P; Rufin P; Basset D; Fadel R; André C
Int Arch Allergy Immunol; 2002 Nov; 129(3):248-53. PubMed ID: 12444323
[TBL] [Abstract][Full Text] [Related]
40. Survey on the safety of a no-updosing regimen of sublingual immunotherapy.
Musarra A; Cilia M; Pecora S; Passalacqua G
Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):313-4. PubMed ID: 17191752
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
